High Value Purity Chemicals API Sitagliptin Phosphate

High Value Purity Chemicals API Sitagliptin Phosphate

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 25.0000 -500.0000

1 Kilogram

FOB Price:USD 25.0000 -500.0000

Min.Order :1 Kilogram
Purity: 99% up
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Sitagliptin Phosphate High purity 99% factory supply

Quick Details

Appearance:White powder
Application: is a new antidiabetic drug, can improve the body's own ability to reduce high blood glucose levels, and the relatively increase naturally occurring incretin by inhibiting the activity of this enzyme
PackAge:1kg/bag ;5kg/drum:25KG/drum
ProductionCapacity:20|Metric Ton|Month
Storage:in low tempreture
Transportation:in low tempreture

Superiority:

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier .

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

Why choose us

1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin

Details:

Product Information

Product name:	Sitagliptin phosphate
CAS:	654671-78-0
Appearance:	White crystalline powder
Purity:	99%

CAS:	654671-78-0
MF:	C16H15F6N5O.H3PO4
MW:	505.31
EINECS:	1806241-263-5
Product Categories:	API;Intermediates & Fine Chemicals;All Inhibitors;Inhibitors;Pharmaceuticals;Pharmaceutical intermdiate
Mol File:	654671-78-0.mol

Usage

Sitagliptin phosphate is dipeptidyl peptidase (DDP-4) inhibitor class of drugs developed by the German Merck company and firstly obtained the US Food and Drug Administration approval for the treatment of type 2 diabetes, is a new antidiabetic drug, can improve the body's own ability to reduce high blood glucose levels, and the relatively increase naturally occurring incretin by inhibiting the activity of this enzyme, including the levels of glucagon-like peptide 1 and glucose-dependent insuline otropic peptide, thereby triggering the pancreas to improve insuline production and stop glucose production in liver, and ultimately reduce the clinical effect of blood glucose concentration.